Evidence map›Paper›PMID 31601627›Full record

ArticleAnnals of the rheumatic diseases2021

Titre-specific positive predictive value of antinuclear antibody patterns.

Jean-Baptiste Vulsteke, Lieve Van Hoovels, Philippe Willems, Bert Vander Cruyssen, Steven Vanderschueren, Rene Westhovens, Daniel Blockmans, Ellen De Langhe, Xavier Bossuyt

Abstract readLetterComment
PubMed Publisher
In one paragraph

Article in Annals of the rheumatic diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Autoimmunity in 2019.Clinical reviews in allergy & immunology · 2020
    Review
  10. Review
  11. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Jean-Baptiste Vulsteke *KU Leuven, Department of Development and Regeneration, Skeletal Biology and Engineering Research Centre, Leuven, Belgium.
Lieve Van Hoovels *Department of Laboratory Medicine, OLV Aalst, Aalst, Belgium.ORCID 0000-0002-3462-7288
Philippe Willems *Department of Laboratory Medicine, GZA Hospitals, Antwerp, Belgium.
Bert Vander CruyssenDepartment of Rheumatology, OLV Aalst, Aalst, Belgium.
Steven VanderschuerenDepartment of General Internal Medicine, University Hospitals Leuven, Leuven, Belgium.
Rene WesthovensKU Leuven, Department of Development and Regeneration, Skeletal Biology and Engineering Research Centre, Leuven, Belgium.
Daniel BlockmansDepartment of General Internal Medicine, University Hospitals Leuven, Leuven, Belgium.
Ellen De LangheKU Leuven, Department of Development and Regeneration, Skeletal Biology and Engineering Research Centre, Leuven, Belgium.
Xavier BossuytDepartment of Microbiology, Immunology and Transplantation, Clinical and Diagnostic Immunology, KU Leuven, Leuven, Belgium xavier.bossuyt@uzleuven.be.ORCID 0000-0001-6856-8485

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antibodies, AntinuclearAutoimmune DiseasesAutoantibodiesAutoimmunityFluorescent Antibody Technique, IndirectHumansPredictive Value of TestsAntibodies, AntinuclearAutoantibodiesautoantibodiesAutoimmune diseasesAutoimmunity

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.